Elix and University of Vienna Aim to Advance Drug Discovery Using AI

Elix and the University of Vienna will partner to bridge the gap between advanced structural biology and artificial intelligence. By integrating AI’s predictive power with experimental atomic-resolution data, the project seeks to bypass the limitations of traditional drug discovery, delivering new therapeutic insights for complex diseases.

The post Elix and University of Vienna Aim to Advance Drug Discovery Using AI appeared first on GEN - Genetic Engineering and Biotechnology News.